SCHEMBL8340820

SCHEMBL8340820

CCOC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=N)C(C(=O)N2CCOCC2)C1c1ccc(C#N)cc1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 20/20 0.61
▸ CYP2C9 P11712 3/20 0.61
▸ CYP3A4 P08684 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8342747 0.93 ELANE (0.63) ELANECYP2C9CYP3A4
SCHEMBL5622517 0.92 ELANE (0.69) ELANECYP2C9CYP3A4
SCHEMBL13378025 0.92 ELANE (0.62) ELANECYP2C9CYP3A4
SCHEMBL5207894 0.85 ELANE (0.69) ELANECYP2C9CYP3A4
SCHEMBL2884242 0.85 ELANE (0.64) ELANECYP2C9CYP3A4
SCHEMBL14498476 0.84 ELANE (0.70) ELANECYP2C9CYP3A4
SCHEMBL5201924 0.84 ELANE (0.68) ELANECYP2C9CYP3A4
SCHEMBL5204844 0.82 ELANE (0.71) ELANECYP2C9CYP3A4
SCHEMBL5204213 0.81 ELANE (0.87) ELANECYP2C9CYP3A4
SCHEMBL8345249 0.81 ELANE (0.69) ELANECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691854-B2 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-06 — — US disclosed
US-7691854-B2 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-06 — — US disclosed
EP-1537081-B1 DIHYDROPYRIDINE DERIVATIVES FOR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS BAYER HEALTHCARE AG (DE) 2008-10-15 — — EP disclosed
WO-2004020412-A1 DIHYDROPYRIDINE DERIVATIVES FOR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS BAYER HEALTHCARE AG (DE) 2004-03-11 — — WO disclosed
Send feedback